These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 21362138)
1. Hyaluronan-CD44 interactions as potential targets for cancer therapy. Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138 [TBL] [Abstract][Full Text] [Related]
2. CD44: structure, function, and association with the malignant process. Naor D; Sionov RV; Ish-Shalom D Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868 [TBL] [Abstract][Full Text] [Related]
3. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. Ghatak S; Hascall VC; Markwald RR; Misra S J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161 [TBL] [Abstract][Full Text] [Related]
4. PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow. Alves CS; Konstantopoulos K PLoS One; 2012; 7(10):e41472. PubMed ID: 23056168 [TBL] [Abstract][Full Text] [Related]
5. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219 [TBL] [Abstract][Full Text] [Related]
7. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen). Raman PS; Alves CS; Wirtz D; Konstantopoulos K Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857 [TBL] [Abstract][Full Text] [Related]
8. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer. Miwa T; Nagata T; Kojima H; Sekine S; Okumura T Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740 [TBL] [Abstract][Full Text] [Related]
9. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606 [TBL] [Abstract][Full Text] [Related]
10. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
11. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Bourguignon LY Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418 [TBL] [Abstract][Full Text] [Related]
13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Yan Y; Zuo X; Wei D Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504 [TBL] [Abstract][Full Text] [Related]
14. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Bourguignon LY; Zhu D; Zhu H Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539 [TBL] [Abstract][Full Text] [Related]
15. A CD44v Hu J; Li G; Zhang P; Zhuang X; Hu G Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837 [TBL] [Abstract][Full Text] [Related]
16. Involvement of hyaluronan and CD44 in cancer and viral infections. Heldin P; Kolliopoulos C; Lin CY; Heldin CH Cell Signal; 2020 Jan; 65():109427. PubMed ID: 31654718 [TBL] [Abstract][Full Text] [Related]
17. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709 [TBL] [Abstract][Full Text] [Related]
18. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions. Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657 [TBL] [Abstract][Full Text] [Related]
19. CD44 and hyaluronan binding by human myeloid cells. Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805 [TBL] [Abstract][Full Text] [Related]
20. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]